Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Zeiss’ Myopia Astigmatism Treatment Approved by FDA

Photonics.com
Nov 2018
DUBLIN, Calif., Nov. 19, 2018 — Zeiss’ medical technology segment has announced FDA premarket approval (PMA) for its ReLEx SMILE system, expanding myopia treatment to patients with astigmatism.

ReLEx SMILE utilizes the high-precision femtosecond laser VisuMax to create a lenticule inside the cornea and an access incision in a single treatment step. Incisions are made through microscopic photodisruptions of tissue created by ultrashort pulses. The PMA also provides for a small entry incision to be made, allowing the SMILE procedure to be potentially less disruptive to the corneal surface tissue.

The VisuMax laser is the first femtosecond laser to receive FDA PMA approval for the treatment of a refractive indication in addition to 510(k) clearances for LASIK flap, keratoplasty, and intrastromal corneal ring. With the approval of ReLEx SMILE, patients can now benefit from a minimally invasive surgery, performed on one laser versus two.

The ReLEx SMILE made its U.S. debut in 2016. In the last 10 years, more than 1.5 million SMILE treatments have been performed worldwide, constituting more than 10 percent of global laser vision correction procedures.

GLOSSARY
myopia
A vision defect commonly referred to as nearsightedness. The defective condition results when the image of a distant object is focused in front of the retina by the relaxed eye. It can be corrected by introducing a negative lens in front of the eye.
BusinessFDAReLEx SMILEeye surgerymyopiaVisuMaxAmericas

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.